Naloxone Drug Combination Buprenorphine FDA Link

A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.

Also Known As:

Buprenorphine, Naloxone Drug Combination; Buprenorphine Naloxone; Buprenorphine Naloxone Drug Combination; Buprenorphine-Naloxone; Buprenorphine-Naloxone Combination; Buprenorphine-Naloxone Drug Combination; Suboxone; Buprenorphine Naloxone Combination; Combination, Buprenorphine-Naloxone; Combination, Buprenorphine-Naloxone Drug; Drug Combination, Buprenorphine-Naloxone; Naloxone, Buprenorphine

Heterocyclic Compounds: 207
- Alkaloids: 5592
  - Opiate Alkaloids: 5977
    - Morphinans: 35
      - Naloxone: 6058
        Naloxone Drug Combination Buprenorphine: 564
      - Buprenorphine: 4375
        Naloxone Drug Combination Buprenorphine: 564
- Bridged-Ring Heterocyclic Compounds
  - Morphinans: 35
    - Naloxone: 6058
      - Naloxone Drug Combination Buprenorphine: 564
    - Buprenorphine: 4375
      - Naloxone Drug Combination Buprenorphine: 564
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Morphinans: 35
      - Naloxone: 6058
        Naloxone Drug Combination Buprenorphine: 564
      - Buprenorphine: 4375
        Naloxone Drug Combination Buprenorphine: 564
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Phenanthrenes: 29
    - Morphinans: 35
      - Naloxone: 6058
        Naloxone Drug Combination Buprenorphine: 564
      - Buprenorphine: 4375
        Naloxone Drug Combination Buprenorphine: 564
Pharmaceutical Preparations
- Drug Combinations: 5500
  - Naloxone Drug Combination Buprenorphine: 564

Kate M Lillie Selected Research

Kate M Lillie Research Topics

Disease

Drug/Important Bio-Agent (IBA)